Moderna (MRNA) has had the highest return since June 4, 2026 by a large-cap US stock, returning 203%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 202.97% |
Chime Financial, Inc Class A Common Stock (CHYM) | 87.39% |
Kymera Therapeutics (KYMR) | 71.35% |
Brinker International (EAT) | 68.88% |
Corcept Therapeutics (CORT) | 64.58% |
Tenet Healthcare (THC) | 64.56% |
Paycom Software (PAYC) | 64.28% |
Charles River Laboratories (CRL) | 62.14% |
Apogee Therapeutics, Inc Common Stock (APGE) | 60.65% |
Atlassian (TEAM) | 59.7% |
Natera (NTRA) | 58.19% |
Glaukos (GKOS) | 58.13% |
SharkNinja (SN) | 57.06% |
DoorDash, Inc Class A Common Stock (DASH) | 52.38% |
Halozyme Therapeutics (HALO) | 51.62% |
Unity Software (U) | 49.53% |
Wayfair (W) | 49.02% |
Repligen (RGEN) | 48.03% |
Expedia (EXPE) | 46.73% |
Tempus AI, Inc Class A Common Stock (TEM) | 46.01% |
Eldorado Gold (EGO) | 45.7% |
Toast (TOST) | 44.13% |
Zebra Technologies (ZBRA) | 43.84% |
PayPal (PYPL) | 42.35% |
Grupo Cibest (CIB) | 42.33% |
Large-cap stocks are treated as having a market cap of $10B+.